WallStreetZenWallStreetZen

NYSE: HIMS
Hims & Hers Health Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for HIMS

Based on 9 analysts offering 12 month price targets for Hims & Hers Health Inc

Min Forecast
$26.00-43.5%
Avg Forecast
$42.89-6.8%
Max Forecast
$68.00+47.76%

Should I buy or sell HIMS stock?

Based on 9 analysts offering ratings for Hims & Hers Health Inc.

Hold
Strong Buy
1 analysts 11.11%
Buy
1 analysts 11.11%
Hold
5 analysts 55.56%
Sell
1 analysts 11.11%
Strong Sell
1 analysts 11.11%
Our proven Zen Rating quant model agrees with analyst consensus with a "Hold" rating. Learn More

Be the first to know when Wall Street analysts revise their HIMS stock forecasts and price targets.

HIMS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-07-17
lockedlocked$00.00+00.00%2025-06-11Find Out Why
lockedlocked$00.00+00.00%2025-06-04
lockedlocked$00.00+00.00%2025-05-06Find Out Why
lockedlocked$00.00+00.00%2025-05-06Find Out Why
Bank of America
Bottom 14%
14
SellMaintains$26.00-43.50%2025-04-29
TD Cowen
Top 33%
68
HoldDowngrades$30.00-34.81%2025-04-29
Leerink Partners
Top 15%
86
HoldMaintains$40.00-13.08%2025-02-25Find out why
Canaccord Genuity
Top 9%
92
Strong BuyMaintains$68.00+47.76%2025-02-19Find out why

1 of 1

Forecast return on equity

Is HIMS forecast to generate an efficient return?

Company
103.63%
Industry
165.16%
Market
-47.51%
HIMS's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is HIMS forecast to generate an efficient return on assets?

Company
31.06%
Industry
14.3%
HIMS is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

HIMS earnings per share forecast

What is HIMS's earnings per share in the next 3 years based on estimates from 6 analysts?

Avg 1 year Forecast
$0.64-26.66%
Avg 2 year Forecast
$0.89+2.4%
Avg 3 year Forecast
$1.24+42.59%
HIMS's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

HIMS revenue forecast

What is HIMS's revenue in the next 3 years based on estimates from 6 analysts?

Avg 1 year Forecast
$2.4B+16.9%
Avg 2 year Forecast
$2.9B+42.1%
Avg 3 year Forecast
$3.4B+68.95%
HIMS's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

HIMS earnings growth forecast

How is HIMS forecast to perform vs Household & Personal Products companies and vs the US market?

Company
11.87%
Industry
7.6%
Market
15.23%
HIMS's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
HIMS's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
HIMS's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

HIMS revenue growth forecast

How is HIMS forecast to perform vs Household & Personal Products companies and vs the US market?

Company
19.02%
Industry
2.71%
Market
10.92%
HIMS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
HIMS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

HIMS vs Household & Personal Product Stocks

TickerPricePrice TargetUp/downsideConsensus
HIMS$46.02$42.89-6.80%Hold
ELF$116.37$125.39+7.75%Strong Buy
CLX$122.17$137.25+12.34%Hold
COTY$4.92$6.30+28.05%Hold
IPAR$112.80$162.00+43.62%Strong Buy
View Top Household & Personal Product Stocks

Hims & Hers Health Stock Forecast FAQ

Is Hims & Hers Health Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 9 Wall Street analysts covering (NYSE: HIMS) stock is to Hold HIMS stock.

Out of 9 analysts, 1 (11.11%) are recommending HIMS as a Strong Buy, 1 (11.11%) are recommending HIMS as a Buy, 5 (55.56%) are recommending HIMS as a Hold, 1 (11.11%) are recommending HIMS as a Sell, and 1 (11.11%) are recommending HIMS as a Strong Sell.

If you're new to stock investing, here's how to buy Hims & Hers Health stock.

What is HIMS's earnings growth forecast for 2025-2027?

(NYSE: HIMS) Hims & Hers Health's forecast annual earnings growth rate of 11.87% is forecast to beat the US Household & Personal Products industry's average forecast earnings growth rate of 7.6%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.23%.

Hims & Hers Health's earnings in 2025 is $193,603,000.On average, 6 Wall Street analysts forecast HIMS's earnings for 2025 to be $144,223,095, with the lowest HIMS earnings forecast at $126,570,965, and the highest HIMS earnings forecast at $164,700,469. On average, 6 Wall Street analysts forecast HIMS's earnings for 2026 to be $201,360,845, with the lowest HIMS earnings forecast at $169,514,686, and the highest HIMS earnings forecast at $235,060,364.

In 2027, HIMS is forecast to generate $280,377,290 in earnings, with the lowest earnings forecast at $267,132,543 and the highest earnings forecast at $311,907,022.

What is HIMS's revenue growth forecast for 2025-2027?

(NYSE: HIMS) Hims & Hers Health's forecast annual revenue growth rate of 19.02% is forecast to beat the US Household & Personal Products industry's average forecast revenue growth rate of 2.71%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.92%.

Hims & Hers Health's revenue in 2025 is $2,013,538,000.On average, 6 Wall Street analysts forecast HIMS's revenue for 2025 to be $532,018,676,952, with the lowest HIMS revenue forecast at $526,738,633,521, and the highest HIMS revenue forecast at $543,973,756,670. On average, 7 Wall Street analysts forecast HIMS's revenue for 2026 to be $646,676,376,217, with the lowest HIMS revenue forecast at $609,665,217,789, and the highest HIMS revenue forecast at $678,284,762,581.

In 2027, HIMS is forecast to generate $768,903,697,270 in revenue, with the lowest revenue forecast at $684,726,320,640 and the highest revenue forecast at $855,122,482,755.

What is HIMS's forecast return on assets (ROA) for 2025-2028?

(NYSE: HIMS) forecast ROA is 31.06%, which is higher than the forecast US Household & Personal Products industry average of 14.3%.

What is HIMS's Price Target?

According to 9 Wall Street analysts that have issued a 1 year HIMS price target, the average HIMS price target is $42.89, with the highest HIMS stock price forecast at $68.00 and the lowest HIMS stock price forecast at $26.00.

On average, Wall Street analysts predict that Hims & Hers Health's share price could fall to $42.89 by Jul 17, 2026. The average Hims & Hers Health stock price prediction forecasts a potential downside of 6.8% from the current HIMS share price of $46.02.

What is HIMS's Earnings Per Share (EPS) forecast for 2025-2027?

(NYSE: HIMS) Hims & Hers Health's current Earnings Per Share (EPS) is $0.87. On average, analysts forecast that HIMS's EPS will be $0.64 for 2025, with the lowest EPS forecast at $0.56, and the highest EPS forecast at $0.73. On average, analysts forecast that HIMS's EPS will be $0.89 for 2026, with the lowest EPS forecast at $0.75, and the highest EPS forecast at $1.04. In 2027, HIMS's EPS is forecast to hit $1.24 (min: $1.18, max: $1.38).

What is HIMS's forecast return on equity (ROE) for 2025-2028?

(NYSE: HIMS) forecast ROE is 103.63%, which is considered strong.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.